These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 14624278)
1. Calcium antagonists and atherosclerosis protection in hypertension. Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278 [TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
3. Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Taddei S; Ghiadoni L; Salvetti A Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362 [TBL] [Abstract][Full Text] [Related]
4. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness]. Zannad F Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857 [TBL] [Abstract][Full Text] [Related]
5. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. Zanchetti A; Rosei EA; Dal Palù C; Leonetti G; Magnani B; Pessina A J Hypertens; 1998 Nov; 16(11):1667-76. PubMed ID: 9856368 [TBL] [Abstract][Full Text] [Related]
6. Long-term protection in at-risk hypertensive patients--a role for nifedipine GITS? Ruilope LM Blood Press; 2002; 11(2):106-9. PubMed ID: 12035870 [TBL] [Abstract][Full Text] [Related]
7. Lacidipine: a review of its use in the management of hypertension. McCormack PL; Wagstaff AJ Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737 [TBL] [Abstract][Full Text] [Related]
8. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P; Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537 [TBL] [Abstract][Full Text] [Related]
9. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). Zanchetti A J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685 [TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine. Haller H; Cosentino F; Lüscher TF Drugs R D; 2002; 3(5):311-23. PubMed ID: 12455152 [TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735 [TBL] [Abstract][Full Text] [Related]
12. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy. Jukema JW; van der Hoorn JW Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641 [TBL] [Abstract][Full Text] [Related]
13. Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). Mancia G; Brown M; Castaigne A; de Leeuw P; Palmer CR; Rosenthal T; Wagener G; Ruilope LM; Hypertension; 2003 Mar; 41(3):431-6. PubMed ID: 12623939 [TBL] [Abstract][Full Text] [Related]
14. The role of calcium antagonists in ischaemic heart disease. Pepine CJ Eur Heart J; 1995 Aug; 16 Suppl H():19-24. PubMed ID: 8846801 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368 [TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists and atherosclerosis. Schachter M Int J Cardiol; 1997 Dec; 62 Suppl 2():S9-15. PubMed ID: 9488190 [TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. Zanchetti A; Magnani B; Dal Palù C J Hum Hypertens; 1992 Dec; 6 Suppl 2():S45-8. PubMed ID: 1289514 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668 [TBL] [Abstract][Full Text] [Related]
19. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Mancia G; Facchetti R; Parati G; Zanchetti A Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453 [TBL] [Abstract][Full Text] [Related]
20. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). Mancia G; Omboni S; Parati G; J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]